RegWardenFDA facility compliance records
Facility

ZOE MEDICAL, INC.

2 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2012: 1 recalls; 2016: 1 inspections; 2019: 1 inspections; 2024: 1 recalls, 1 inspections1’12’13’14’151’16’17’181’19’20’21’22’232’24’25’26
  • Recalls (2)
  • Inspections (3)

Devices registered here (2)

Recalls & enforcement

  • Class IIOngoing2024-08-13
    This product labeling does not adequately provide warning about the risks associated with the use of damaged batteries or batteries past the intended use life.
  • Class IITerminated2012-06-06
    Unit fails to power up, resulting in an equipment alarm

FDA inspections (3)

  • VAI2024-05-31
    Voluntary Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
  • NAI2019-09-20
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
  • NAI2016-10-12
    No Action Indicated · Compliance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “ZOE MEDICAL, INC. (FEI 3003294644) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3003294644-zoe-medical-inc/

Not open yet

Alerts for ZOE MEDICAL, INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.